Project Baseline Health Study

All Clinical Trial

Official title:

Project Baseline Health Study

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT03154346
• Other study ID #: 2017-BL-001
• Status: Active, not recruiting
• Start date: March 29, 2017
• Est. completion date: December 2023

Study information

• Verified date: November 2022
• Source: Baseline Study LLC
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

This study is the first initiative of Project Baseline, a broader effort designed to develop a well-defined reference, or "baseline," of good health as well as a rich data platform that may be used to better understand the transition from health to disease and identify additional risk factors for disease. Project Baseline endeavors to test and develop new tools and technologies to collect, organize, and activate health information.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 10000
• Est. completion date: December 2023
• Est. primary completion date: December 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Age = 18
• U.S. Resident
• Able to speak and read English
• Willing and able to comply with all aspects of the protocol

Exclusion Criteria:

• Individuals working on Project Baseline, including the Baseline Study
• Known severe allergy to nickel or metal jewelry

Related Conditions & MeSH terms

• All

Locations

Country	Name	City	State
United States	Duke University School of Medicine	Durham	North Carolina
United States	Duke University School of Medicine	Kannapolis	North Carolina
United States	Baseline Study	South San Francisco	California
United States	Stanford Medicine	Stanford	California
United States	California Health and Longevity Institute	Westlake Village	California

Sponsors (5)

Lead Sponsor	Collaborator
Baseline Study LLC	Duke University, Google LLC., Stanford University, Verily Life Sciences LLC

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Develop a set of scalable and standardized tools for acquiring, organizing, and analyzing clinical, molecular, imaging, sensor, self-reported, behavioral, environmental, and other health-related measurements		For the duration of the study
Primary	Evaluate the use of sensor technologies for the collection of continuous, accurate health information		For the duration of the study
Primary	Create a dataset encompassing a wide spectrum of phenotypic measures for future exploratory analysis		For the duration of the study
Primary	Measure the phenotypic diversity observed among a participant population, defining a range of expected values for multiple types of data		For the duration of the study
Primary	Identify biomarkers of disease-related transitions, including those related to cardiovascular disease and cancer		For the duration of the study